Medical Innovation Exchange

FDA placed hold on Fulcrum's sickle cell therapy over hematological malignancy concerns

https://www.fiercebiotech.com/biotech/fda-placed-hold-fulcrums-sickle-cell-therapy-over-hematological-malignancy-concerns

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!